Tina Bhutani, MD, MAS, FAAD: Use of Spesolimab for Generalized Pustular Psoriasis episode artwork

EPISODE · Jun 4, 2026 · 6 MIN

Tina Bhutani, MD, MAS, FAAD: Use of Spesolimab for Generalized Pustular Psoriasis

from The Journal of Clinical and Aesthetic Dermatology · host Matrix Medical Communications

Send us Fan MailTina Bhutani, MD, MAS, FAAD, discusses the use of spesolimab, an interleukin-36 receptor blocker, for the treatment of patients with generalized pustular psoriasis. Drawing on real-world patient cases, she highlights its role in rapidly controlling acute flares, improving patient quality of life, and reducing reliance on therapies originally developed for plaque psoriasis.

Episode metadata supplied by the publisher feed · Published Jun 4, 2026

Embed this episode

Ready to play

Tina Bhutani, MD, MAS, FAAD: Use of Spesolimab for Generalized Pustular Psoriasis

0:00 6:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Journal of Clinical and Aesthetic Dermatology?

This episode is 6 minutes long.

When was this The Journal of Clinical and Aesthetic Dermatology episode published?

This episode was published on June 4, 2026.

Can I download this The Journal of Clinical and Aesthetic Dermatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!